The global cannabis use disorder market is rapidly expanding, driven by increased recognition of cannabis use as a public health issue and the ongoing development of investigational treatments, ...

When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to ...

As a next-generation selective S1P receptor modulator, VELSIPITY® offers the potential for rapid onset of action, and long-lasting clinical remission and mucosal healing through an oral, once-daily ...

OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM” or the "Company”), today that ...

A team of UK researchers working at the University of Leeds, supported by colleagues from University College London (UCL) and ...

Esoteric’s N-05XE and S-05XE combine flagship DAC, streaming, balanced preamp, serious headphone amp, and Class A power—but at $26,500, is this the most future-proof “affordable” reference system?

A Fairy Story (Animal Farm) is at Tobacco Factory Theatres on February 5-7 at 7.30pm, with an additional 2.30pm matinee show ...

POET Technologies Inc. stock fell on dilution fears, but new capital may drive bigger gains. Click for this updated look at ...

In one instance, to further enhance output voltage swing and linearity, the authors propose a novel “breakdown-voltage (BV) ...

The team found that in Parkinson’s patients, the SCAN shows excessive connectivity to subcortical regions, including the ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approvalSEATTLE, Feb. 5, 2026 ...